University of Minnesota. Driven to Discover.
Peramivir, made by BioCryst, is intended to be given to influenza patients in a single intravenous dose.
Almost 70% of H3N2 strains are mismatched with the vaccine, and 4 more kids have died.
An H3N2 mismatch may portend a tough season and raises vaccine questions.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.